Literature DB >> 22116147

A novel real-time PCR method for determination and quantification of each cytomegalovirus glycoprotein H subtype in clinical samples.

Kazufumi Ikuta1, Ken Ishioka, Yuka Sato, Takashi Imamura, Kimisato Asano, Shin Koyano, Naoki Inoue, Tatsuo Suzutani.   

Abstract

To investigate reinfection in patients with congenital cytomegalovirus (CMV) infection, we established a CMV subtype-specific real-time quantitative PCR method targeting the CMV gH epitope region that can be used for evaluating pathogenic CMV strains in cases of mixed CMV infection.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22116147      PMCID： PMC3264147          DOI： 10.1128/JCM.06032-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  20 in total

1.  Prevalence of maternal cytomegalovirus (CMV) antibody and detection of CMV DNA in amniotic fluid.

Authors:  N Nishimura; H Kimura; Y Yabuta; N Tanaka; Y Ito; K Ishikawa; C Suzuki; T Morishima
Journal:  Microbiol Immunol       Date:  1999       Impact factor: 1.955

2.  Secondary maternal cytomegalovirus infection--A significant cause of congenital disease.

Authors:  K Ahlfors; S A Ivarsson; S Harris
Journal:  Pediatrics       Date:  2001-05       Impact factor: 7.124

3.  Genetic variations in the gB, UL144 and UL149 genes of human cytomegalovirus strains collected from congenitally and postnatally infected Japanese children.

Authors:  Hainian Yan; Shin Koyano; Yuhki Inami; Yumiko Yamamoto; Tatsuo Suzutani; Masashi Mizuguchi; Hiroshi Ushijima; Ichiro Kurane; Naoki Inoue
Journal:  Arch Virol       Date:  2008-02-14       Impact factor: 2.574

4.  Single cytomegalovirus strain associated with fetal loss and then congenital infection of a subsequent child born to the same mother.

Authors:  Tsunehisa Nagamori; Shin Koyano; Naoki Inoue; Hideto Yamada; Miho Oshima; Toshio Minematsu; Kenji Fujieda
Journal:  J Clin Virol       Date:  2010-08-03       Impact factor: 3.168

5.  Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.

Authors:  S B Boppana; L B Rivera; K B Fowler; M Mach; W J Britt
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

6.  Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents.

Authors:  S L Rosenthal; L R Stanberry; F M Biro; M Slaoui; M Francotte; M Koutsoukos; M Hayes; D I Bernstein
Journal:  Clin Infect Dis       Date:  1997-02       Impact factor: 9.079

7.  Association between genital tract cytomegalovirus infection and bacterial vaginosis.

Authors:  Shannon A Ross; Zdenek Novak; Guha Ashrith; Lisa B Rivera; William J Britt; Spencer Hedges; Jane R Schwebke; And Suresh Boppana
Journal:  J Infect Dis       Date:  2005-10-07       Impact factor: 5.226

8.  The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific.

Authors:  M Urban; W Britt; M Mach
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

9.  Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population.

Authors:  Marisa M Mussi-Pinhata; Aparecida Y Yamamoto; Rosângela M Moura Brito; Myriam de Lima Isaac; Patricia F de Carvalho e Oliveira; Suresh Boppana; William J Britt
Journal:  Clin Infect Dis       Date:  2009-08-15       Impact factor: 9.079

10.  Cytomegalovirus reinfections in healthy seroimmune women.

Authors:  Shannon A Ross; Nitin Arora; Zdenek Novak; Karen B Fowler; William J Britt; Suresh B Boppana
Journal:  J Infect Dis       Date:  2010-02-01       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.